Company Information
- Type:
- Company
- Country:
- Mexico
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 31 July 2006
- Next Communication on Progress (COP) due on:
- 31 July 2025
Communication On Progress
Published On | Title | Level/Status |
---|---|---|
19-Jun-2024 | 2024 Communication on Progress | Submitted |
05-Aug-2022 | Reporte Social 2021 | Advanced |
05-Aug-2021 | Reporte Social 2020 | Advanced |
05-Aug-2020 | Reporte Social 2019 | Advanced |
08-Jul-2019 | Reporte Social 2018 | Advanced |
08-Jul-2019 | Communication on Progress | Active |
08-Aug-2018 | Reporte Social 2017 | Advanced |
05-Sep-2017 | Reporte Social 2016 | Advanced |
19-Sep-2016 | Communication on Progress | Advanced |
03-Oct-2015 | Reporte Social 2014 | Advanced |
03-Oct-2014 | Reporte Social 2013 | Advanced |
03-Oct-2013 | Reporte Social Liomont 2012 | Advanced |
24-Sep-2013 | Grace Letter | Not applicable |
20-Sep-2012 | Reporte Social Laboratorios Liomont 2011 | Advanced |
19-Sep-2011 | Reporte Social 2010 | Active |
16-Sep-2010 | 2010 Communication on Progress | Not applicable |
12-May-2009 | Responsabilidad Social Corporativa - Informe 2008 | Not applicable |
29-Aug-2008 | Reporte Social 2007 | Not applicable |
13-Sep-2007 | Reporte Social 2006 | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.